{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 4475"}, "official-title": {"#tail": "\n\t", "#text": "To allow the manufacture, importation, distribution, and sale of investigational drugs and devices\n\t\t\t intended for use by terminally ill patients who execute an informed\n\t\t\t consent document, and for other purposes."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140410", "#text": "April 10, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, "sponsor": {"#tail": " (for himself and ", "#text": "Mr. Griffith of Virginia", "@name-id": "G000568"}, "cosponsor": {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Mr. Hanna", "@name-id": "H001051"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H179495C265634A20A469C4B6E895AF66", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Compassionate Freedom of Choice Act of 2014", "@value": "Compassionate Freedom of Choice Act of 2014", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H8662678E1FA848859AB8A05EA30687F5"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " is amended by inserting after ", "@entity-type": "act", "#text": "Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act"}, "#text": "The ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " the following:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 561", "@value": "Federal Food, Drug, and Cosmetic Act/s:561"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C.\n\t\t\t 360bbb", "@value": "usc/21/360bbb"}], "@entity-type": "law-citation", "#text": "\n          "}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Drugs and devices for use by terminally ill patients"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "section": {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "561A."}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Drugs and devices for use by terminally ill patients"}, "subsection": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " prevents or restricts, and the\n\t\t\t ", "@entity-type": "act", "#text": "section 351 of the Public Health Service Act", "@value": "Public Health Service Act/s:351"}, {"#tail": " shall not implement or enforce any provision\n\t\t\t of law preventing or restricting, the manufacture, importation,\n\t\t\t distribution, or sale of an investigational drug or device intended for\n\t\t\t use by a terminally ill patient in accordance with ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:561A/ss:b", "@proposed": "true"}], "#text": "Nothing in this Act or ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(a)"}, "header": {"#tail": "\n            ", "#text": "In general"}, "#text": "\n            ", "@id": "HC7C3012F9BC14692A750EF396DC3482C"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "In order for an investigational drug or device to be intended for use in accordance with this\n\t\t\t subsection, such drug or device must be intended for use by a patient who\n\t\t\t has\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(b)"}, "header": {"#tail": "\n            ", "#text": "Patient requirements"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "been diagnosed with a terminal illness by a licensed physician;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "H33EC5D613B1F4F49BE009FAC14B4ED2D", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "been informed by a licensed physician that no drug or device that is lawfully marketed in the\n\t\t\t United States is likely to cure the illness; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@id": "H715D1572BBA043D5AEF812AC49B01201", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "executed a written informed consent document that states\u2014"}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "#text": "\n              ", "@id": "HC64C1224E9AF47F6A8603534ED0BD921", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the known and potential risks and benefits of such drug or device; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H2D362DCF159146A79D700C0B645BC4FC", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "any indications of the illness for which a drug or device is lawfully marketed, or for which\n\t\t\t treatment is otherwise available, in the United States.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HB1F43EE8C3254881BC60E95800E01CFC", "#text": "\n                "}]}], "#text": "\n            ", "@id": "H64F8C6DE2CA049B680DF1C772E7B6CA4"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Prohibition on requiring the disclosure, collection, and reporting of certain information by Food\n\t\t\t and Drug Administration"}, "paragraph": [{"#tail": "\n            ", "@id": "H071FCA0B3A7B44F7A123061B0E9C3131", "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In general"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may not require the disclosure, collection, or reporting of\u2014", "@entity-type": "federal-body", "#text": "Commissioner of Food and Drugs", "@entity-id": "7524"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "any information related to the delivery, administration, or use of an investigational drug or\n\t\t\t device pursuant to this section; or"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H0350DD5D79E344FAAE612B1E94390AAD", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "any information related to the clinical outcomes experienced by a terminally ill patient supplied\n\t\t\t an investigational drug or device pursuant to this section."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HCAEDFE7FD1B5463CB08D13A4C2B29B5F", "#text": "\n                "}]}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "Nothing in this subsection prevents the sponsor of a clinical trial from voluntarily disclosing,\n\t\t\t collecting, or reporting information to the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Exception"}, "#text": "\n              ", "@id": "H6C773D2E5A5D48B28F31E263A48C23CF"}], "#text": "\n            ", "@id": "HCC39993D77674D87AE6750A50791F91B"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " means a drug or device that\u2014", "#text": "investigational drug or device"}, "#text": "In this section, the term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(d)"}, "header": {"#tail": "\n            ", "#text": "Definition of investigational drug or device"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ",\n\t\t\t ", "@entity-type": "act", "#text": "section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": ", or ", "@entity-type": "act", "#text": "510(k)", "@value": "Federal Food, Drug, and Cosmetic Act/s:510/ss:k"}, {"#tail": " or ", "@entity-type": "act", "#text": "515 of this Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:515"}, {"#tail": ", and cannot otherwise be lawfully marketed in the United States; and", "@entity-type": "act", "#text": "section 351 of the Public Health Service\n\t\t\t Act", "@value": "Public Health Service Act/s:351"}], "#text": "has not yet been approved, licensed, or cleared for commercial distribution under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "H9A390AEAF130423E9F66234A3229D5A1", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "#text": "is or has been the subject of one or more clinical trials."}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@id": "HBF15B86D987C41F6A9D7EAF9B2F92378", "#text": "\n              "}], "#text": "\n            ", "@id": "HFA863D440FD445B78F79E1FE7FA3A2F8"}], "#text": "\n          ", "@id": "H2EE2EADC8A7E4F57A00AE8288FE6C29A"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t", "@id": "H12C03DFC99824EE993A0CCDE5823458E"}, "#text": "\n      ", "@id": "H3014851AEA674AB3920FAA6AFEA5D295"}, {"#tail": "\n  ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as inserted by ", "@entity-type": "act", "#text": "section 561A", "@value": "Federal Food, Drug, and Cosmetic Act/s:561A", "@proposed": "true"}, {"#tail": ", the following:", "@entity-type": "act", "#text": "section 2 of this Act", "@value": "Compassionate Freedom of Choice Act of 2014/s:2", "@proposed": "true"}], "#text": "The ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by inserting after\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "uscode", "#text": "21 U.S.C. 301 et seq", "@value": "usc/21/301/etseq"}, "@parsable-cite": "usc/21/301", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Liability protection"}, "quoted-block": {"#tail": "\n\t\t", "section": {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall not be liable in any\n\t\t\t action under Federal or State law for any loss, damage, or injury arising\n\t\t\t out of, relating to, or resulting from\u2014", "@entity-type": "act", "#text": "section 561A", "@value": "Federal Food, Drug, and Cosmetic Act/s:561A", "@proposed": "true"}, "#text": "Except in the case of gross negligence or willful misconduct, any person who manufactures, imports,\n\t\t\t distributes, prescribes, dispenses, or administers an investigational drug\n\t\t\t or device in accordance with ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n          ", "#text": "561B."}, "header": {"#tail": "\n          ", "#text": "Liability protection"}, "paragraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "the design, development, clinical testing and investigation, manufacturing, labeling, distribution,\n\t\t\t sale, purchase, donation, dispensing, prescription, administration, or use\n\t\t\t of the drug or device; or"}, "enum": {"#tail": "\n            ", "#text": "(1)"}, "#text": "\n            ", "@id": "H5AC299554B264CBA8F20EE1013B54C93", "@commented": "no"}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "the safety or effectiveness of the drug or device."}, "enum": {"#tail": "\n            ", "#text": "(2)"}, "#text": "\n            ", "@id": "H5CF0E58F446A421FB7A094B7B6C94EEB", "@commented": "no"}], "#text": "\n          ", "@id": "H4EA648F960074F10BCC83239D1E77936", "@commented": "no"}, "#text": "\n\t\t\t\t", "@id": "HF23DFB79B2C445C982F65DC0212FD61F", "after-quoted-block": {"#tail": "\n      ", "#text": "."}}, "#text": "\n      ", "@id": "H16ACEB9DF7E147F6A3B27CE91E30D543", "@commented": "no"}], "#text": "\n\t\t", "@id": "HE05B1A379F7B4C93A4CEEBD339F1B619"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-04-10"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 4475 IH: Compassionate Freedom of Choice Act of 2014"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}